Josh Zeidman

Josh Zeidman serves as the Senior Vice President of Business Development at PHIL, Inc., focusing on enhancing commercial success and patient experiences for retail and specialty-lite pharmaceutical brands through innovative solutions. Previously, at Caresyntax, Josh held multiple roles including Chief Business Officer and Acting Chief Financial Officer, advancing data-driven surgical practices. With a tenure as Vice President of Business Development at Kinta Artificial Intelligence, Josh led efforts in AI-powered manufacturing digitization. Experience also includes strategic roles at Science Exchange and the Boston Consulting Group, where efforts concentrated on biopharma and operational efficiency. Josh Zeidman earned a Bachelor of Science in Chemical-biological engineering from the Massachusetts Institute of Technology.